4DMedical Limited (4DX.AX)
AUD 0.46
(1.11%)
AUD 0.46
(1.11%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 | 3.51 Million AUD | 1318.16% |
| 2023 | 248.03 Thousand AUD | -11.61% |
| 2022 | 280.61 Thousand AUD | 124.27% |
| 2021 | 125.12 Thousand AUD | 101.54% |
| 2020 | -8.13 Million AUD | -118.25% |
| 2019 | -3.72 Million AUD | -23.62% |
| 2018 | -3.01 Million AUD | -2.84% |
| 2017 | -2.93 Million AUD | -1009.62% |
| 2016 | 322.27 Thousand AUD | 28.29% |
| 2015 | 251.19 Thousand AUD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 FY | -28.37 Million AUD | -11541.72% |
| 2024 Q1 | 371.01 Thousand AUD | 102.92% |
| 2024 Q4 | 1.38 Million AUD | 0.0% |
| 2024 Q2 | -12.81 Million AUD | -3553.46% |
| 2024 Q3 | 1.38 Million AUD | 110.83% |
| 2023 Q3 | 115.94 Thousand AUD | 101.0% |
| 2023 FY | 248.03 Thousand AUD | -11.61% |
| 2023 Q1 | 226.27 Thousand AUD | 102.03% |
| 2023 Q4 | -12.7 Million AUD | -11060.94% |
| 2023 Q2 | -11.56 Million AUD | -5212.79% |
| 2022 Q1 | 48.87 Thousand AUD | 100.83% |
| 2022 Q2 | -9.3 Million AUD | -19143.71% |
| 2022 Q4 | -11.12 Million AUD | -12264.61% |
| 2022 FY | 280.61 Thousand AUD | 124.27% |
| 2022 Q3 | 91.43 Thousand AUD | 100.98% |
| 2021 Q3 | 25.82 Thousand AUD | 100.42% |
| 2021 FY | 125.12 Thousand AUD | 101.54% |
| 2021 Q2 | -6.17 Million AUD | -16918.59% |
| 2021 Q1 | 36.73 Thousand AUD | 100.72% |
| 2021 Q4 | -5.86 Million AUD | -22817.37% |
| 2020 Q1 | 59.22 Thousand AUD | 87.89% |
| 2020 Q3 | -3532.00 AUD | 99.88% |
| 2020 Q4 | -5.11 Million AUD | -144689.58% |
| 2020 FY | -8.13 Million AUD | -118.25% |
| 2020 Q2 | -2.84 Million AUD | -4896.47% |
| 2019 Q4 | 31.52 Thousand AUD | 0.0% |
| 2019 Q2 | 285.00 AUD | 0.0% |
| 2019 Q1 | 285.00 AUD | 0.0% |
| 2019 FY | -3.72 Million AUD | -23.62% |
| 2019 Q3 | 31.52 Thousand AUD | 10960.35% |
| 2018 FY | -3.01 Million AUD | -2.84% |
| 2017 FY | -2.93 Million AUD | -1009.62% |
| 2016 FY | 322.27 Thousand AUD | 28.29% |
| 2015 FY | 251.19 Thousand AUD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Adherium Limited | -640.83 Thousand AUD | 648.899% |
| Aroa Biosurgery Limited | 53.98 Million AUD | 93.485% |
| Atomo Diagnostics Limited | 1.43 Million AUD | -144.834% |
| Anteris Technologies Ltd | 2.51 Million AUD | -39.741% |
| Control Bionics Limited | 3.67 Million AUD | 4.227% |
| CardieX Limited | 10.1 Million AUD | 65.2% |
| Compumedics Limited | 26.06 Million AUD | 86.506% |
| Cochlear Limited | 1.69 Billion AUD | 99.793% |
| CleanSpace Holdings Limited | 11.35 Million AUD | 69.034% |
| Cyclopharm Limited | 4.49 Million AUD | 21.786% |
| EMVision Medical Devices Ltd | 11.21 Million AUD | 68.647% |
| Nova Eye Medical Limited | 20.19 Million AUD | 82.58% |
| HeraMED Limited | -504.09 Thousand AUD | 797.793% |
| Imricor Medical Systems, Inc. | -1.99 Million AUD | 276.504% |
| ImpediMed Limited | 9 Million AUD | 60.938% |
| InhaleRx Limited | 1.2 Million AUD | -192.143% |
| LBT Innovations Limited | -2.91 Million AUD | 220.588% |
| Micro-X Limited | 5.73 Million AUD | 38.687% |
| Neurotech International Limited | -5867.00 AUD | 60054.645% |
| OncoSil Medical Limited | 55.63 Thousand AUD | -6222.87% |
| PolyNovo Limited | 36.08 Million AUD | 90.252% |
| Respiri Limited | 456.91 Thousand AUD | -669.847% |
| SomnoMed Limited | 55.13 Million AUD | 93.62% |
| Universal Biosensors, Inc. | 4.28 Million AUD | 17.909% |
| Uscom Limited | 3.11 Million AUD | -12.897% |
| Visioneering Technologies, Inc. | -271.11 Thousand AUD | 1397.43% |